All Cancer articles – Page 3
-
CommentLabour’s inheritance on RTT waiting times
At the end of the last government, waiting times were bad but no longer getting worse.
-
NewsTrust seeks more income to shore up planned cancer centre
A trust’s £750m redevelopment project is facing an “affordability challenge”, raising questions over a proposed new cancer centre.
-
HSJ PartnersHow can NHS and industry partnerships transform patient care?
Rachel Houlding, national oncology healthcare director at MSD, discusses highlights from a recent award-winning NHS partnership that could help you to transform your patient pathways
-
HSJ PartnersA model of efficiency: Reducing cancelled procedures with digital prep support
One in 20 colonoscopies do not go ahead as planned due to poor or insufficient prep. King’s College Hospital’s Mayur Kumar explains how his trust worked with Healthcare Communications to reduce cancellations by 28 per cent, saving £336,000 a year.
-
NewsCancer treatment ‘biased against ethnic minorities’
A type of cancer treatment used in the NHS appears to be biased against non white European patients, research has found.
-
CommentWhy a focus on waiting time targets may neglect the poorest cancer patients
Naser Turabi explains how ensuring equitable access to cancer treatment is crucial.
-
HSJ PartnersCross-pathway efforts are needed to optimise multi-modality treatment for non-small cell lung cancer
After decades with little progress, the treatment landscape for lung cancer has dramatically transformed. However, experts at a roundtable event highlighted that the NHS is struggling to keep up with such rapid progress, and changes across the pathway are urgently needed to optimise outcomes from multi-modality treatment.
-
HSJ PartnersCould better screening reduce the slide in UK cancer outcomes?
Deloitte sheds light on the barriers faced by vulnerable populations, disparities in cancer screening, and strategies for equitable access.
-
NewsStreeting commits to hit four-hour target in first term
Wes Streeting has reiterated Labour’s commitment to hitting all the NHS’s headline performance standards in its first term, including the four-hour A&E target, if it wins power.
-
NewsHospital forced to close sterile unit after leak
A trust has been forced to close its sterile drugs production unit due to “increasing infrastructure weakness”, risking a £3m annual bill for purchasing the medicines.
-
NewsSix trusts drop into ‘most challenged’ group
Six more trusts have dropped into the “tier 1” group for the most challenged providers for their elective or cancer performance.
-
NewsNHSE will not extend high-profile cancer test pilot
NHS England has decided not to extend the use of a high-profile emerging cancer screening technology, casting further doubt on its target to improve early detection.
-
HSJ Local‘Patients are choosing palliative care over cancer treatment’ due to lack of local services, CEO warns
Patients in part of the East of England are choosing to begin palliative care over cancer treatment because of prohibitive travel times and costs to get to the nearest specialist centre, a local system leader has warned.
-
HSJ InteractiveHow might pathways evolve to free up capacity in cancer care?
An HSJ roundtable, fully funded and initiated by AbbVie, considered which pathway changes might support best use of capacity
-
NewsExclusive: NHSE targeting 50% cut to waiting list
NHS England is floating proposals to cut the elective waiting list by nearly 50 per cent to under 4 million over the next five years, HSJ can reveal.
-
HSJ PartnersBetter, faster, stronger: Incentivising capacity for NHS cancer care
By prioritising a new approach to incentives, policymakers can help create system capacity in cancer services, especially at a time when organisational reform and major financial investment are unlikely, writes David Brocklehurst
-
HSJ LocalTrust ‘fighting losing battle’ over elective waits, CEO admits
A hospital chief executive has blamed a “mind-blowing increase” in cancer referrals for his trust’s deterioration in performance on long elective waits.
-
NewsContamination risk may cost trust £50m a year
A trust could face a £50m yearly bill for outsourcing preparation of chemotherapy drugs, after external inspections raised concern about a leaking roof and other infection risks.
-
NewsNHSE looks to match Scotland on cancer tests
NHS England is piloting a scheme to lower the threshold for getting a bowel cancer scan after screening, which would bring it in line with standards in Scotland.
-
Expert BriefingNorth by North West: Skin in the game
Essential insight into NHS matters in the North West of England. Contact me in confidence here.